Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 21, 2021 Filed Mar 23, 2021 20:04 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Tax withholdingCommon Stock | 2,118 | $143.83 | $304,631.94 |
DisclosureSEC source: 0001127602-21-011809 · form4.xml · nonDerivative · entry 2 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,009 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award to cover the estimated tax withholding obligation. F3 · balance_after: Includes 88,009 restricted stock units which the reporting person has deferred. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:04 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GrantCommon Stock | 90,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011809 · form4.xml · nonDerivative · entry 1 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,127 F1 · shares: On 3/21/21 shares vested from a performance-based restricted stock unit award and the reporting person deferred receipt of the shares. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:03 UTC |
Callen David REVP & CFO
|
Tax withholdingCommon Stock | 7,042 | $143.83 | $1,012,850.86 |
DisclosureSEC source: 0001127602-21-011808 · form4.xml · nonDerivative · entry 2 Callen David R · CIK 0001418784 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,877 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award to cover the estimated tax withholding obligation. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:03 UTC |
Callen David REVP & CFO
|
GrantCommon Stock | 15,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011808 · form4.xml · nonDerivative · entry 1 Callen David R · CIK 0001418784 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,919 F1 · shares: On 3/21/21 shares vested from a performance-based restricted stock unit award. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:02 UTC |
Brown Kevin KennedyEVP and CMO
|
Tax withholdingCommon Stock | 3,241 | $143.83 | $466,153.03 |
DisclosureSEC source: 0001127602-21-011807 · form4.xml · nonDerivative · entry 2 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,267 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award to cover the estimated tax withholding obligation. F3 · balance_after: Includes 6,559 restricted stock units that the reporting person has deferred. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:02 UTC |
Brown Kevin KennedyEVP and CMO
|
GrantCommon Stock | 13,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011807 · form4.xml · nonDerivative · entry 1 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,508 F1 · shares: On 3/21/21 shares vested from a performance-based restricted stock unit award. The reporting person deferred receipt of a portion of the award. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:01 UTC |
Bloomquist Andrea LeeEVP, Chief Innovation Officer
|
Tax withholdingCommon Stock | 5,929 | $143.83 | $852,768.07 |
DisclosureSEC source: 0001127602-21-011806 · form4.xml · nonDerivative · entry 2 Bloomquist Andrea Lee · CIK 0001551521 · EVP, Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,121 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award to cover the estimated tax withholding obligation. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:01 UTC |
Bloomquist Andrea LeeEVP, Chief Innovation Officer
|
GrantCommon Stock | 13,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011806 · form4.xml · nonDerivative · entry 1 Bloomquist Andrea Lee · CIK 0001551521 · EVP, Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,050 F1 · shares: On 3/21/21 shares vested from a performance-based restricted stock unit award. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:00 UTC |
Barra MelissaEVP, Chief Sales & Services
|
Tax withholdingCommon Stock | 4,901 | $143.83 | $704,910.83 |
DisclosureSEC source: 0001127602-21-011805 · form4.xml · nonDerivative · entry 2 Barra Melissa · CIK 0001630667 · EVP, Chief Sales & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,546 F2 · shares: These shares were withheld from the vesting of a performance-based restricted stock unit award to cover the estimated tax withholding obligation. Read SEC document |
| March 21, 2021 Filed Mar 23, 2021 20:00 UTC |
Barra MelissaEVP, Chief Sales & Services
|
GrantCommon Stock | 11,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011805 · form4.xml · nonDerivative · entry 1 Barra Melissa · CIK 0001630667 · EVP, Chief Sales & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,447 F1 · shares: On 3/21/21 shares vested from a performance-based restricted stock unit award. Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:09 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 22,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011020 · form4.xml · nonDerivative · entry 3 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Family Trust Disclosed balance after: 138,069 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:09 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GiftCommon Stock | 22,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-011020 · form4.xml · nonDerivative · entry 2 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 16, 2021 Filed Mar 17, 2021 20:09 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Tax withholdingCommon Stock | 16,904 | $142.10 | $2,402,058.40 |
DisclosureSEC source: 0001127602-21-011020 · form4.xml · nonDerivative · entry 1 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,179 F1 · shares: On March 16, 2021, the reporting person took receipt of 39,083 deferred Restricted Stock Units. These shares were withheld to cover the reporting person's estimated tax obligation. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:13 UTC |
Saklad Joseph HunterEVP, Chief Supply Chain Office
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011024 · form4.xml · derivative · entry 2 Saklad Joseph Hunter · CIK 0001604680 · EVP, Chief Supply Chain Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Stock · 2,645 shares Expires 2031-03-15 F2 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:12 UTC |
Poirier Robert JosephVP, CAO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 495 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011022 · form4.xml · derivative · entry 2 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495 Underlying: Common Stock · 495 shares Expires 2031-03-15 F3 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:12 UTC |
Poirier Robert JosephVP, CAO
|
Tax withholdingCommon Stock | 65 | $146.97 | $9,553.05 |
DisclosureSEC source: 0001127602-21-011022 · form4.xml · nonDerivative · entry 1 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 F1 · shares: On 3/15/21 shares vested from a restricted stock unit award. These shares were withheld from the vesting to cover the reporting person's estimated tax obligation. F2 · balance_after: Includes 956 shares from Restricted Stock Unit awards that vest over time. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:10 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,075 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011021 · form4.xml · derivative · entry 3 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075 Underlying: Common Stock · 2,075 shares Expires 2031-03-15 F2 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:09 UTC |
Ibach Shelly RadueDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,880 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011020 · form4.xml · derivative · entry 5 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,880 Underlying: Common Stock · 21,880 shares Expires 2031-03-15 F2 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:07 UTC |
Hellfeld Samuel RSVP Chief Legal & Risk Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,265 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011018 · form4.xml · derivative · entry 3 Hellfeld Samuel R · CIK 0001750478 · SVP Chief Legal & Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265 Underlying: Common Stock · 2,265 shares Expires 2031-03-15 F2 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:06 UTC |
Callen David REVP & CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 4,150 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011016 · form4.xml · derivative · entry 2 Callen David R · CIK 0001418784 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,150 Underlying: Common Stock · 4,150 shares Expires 2031-03-15 F2 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:05 UTC |
Brown Kevin KennedyEVP and CMO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011014 · form4.xml · derivative · entry 3 Brown Kevin Kennedy · CIK 0001596057 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,645 Underlying: Common Stock · 2,645 shares Expires 2031-03-15 F1 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:04 UTC |
Bloomquist Andrea LeeEVP, Chief Innovation Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,585 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011013 · form4.xml · derivative · entry 2 Bloomquist Andrea Lee · CIK 0001551521 · EVP, Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,585 Underlying: Common Stock · 3,585 shares Expires 2031-03-15 F1 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:02 UTC |
Barra MelissaEVP, Chief Sales & Services
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,490 | $0.00 Strike: $146.97 | $0.00 |
DisclosureSEC source: 0001127602-21-011011 · form4.xml · derivative · entry 2 Barra Melissa · CIK 0001630667 · EVP, Chief Sales & Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,490 Underlying: Common Stock · 3,490 shares Expires 2031-03-15 F1 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/15/22, 3/15/23 and 3/15/24. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:03 UTC |
Alegre DanielDirector
|
GrantCommon Stock | 152 | $139.36 | $21,182.72 |
DisclosureSEC source: 0001127602-21-010590 · form4.xml · nonDerivative · entry 1 Alegre Daniel · CIK 0001576237 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,396 F1 · shares: The reporting person elected to receive his Board fees in common stock. F2 · balance_after: Includes 1,815 restricted stock units that will vest over time. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:02 UTC |
Matas Barbara RuthDirector
|
GrantPhantom Stock · Derivative | 179.39 | $139.36 | $24,999.79 |
DisclosureSEC source: 0001127602-21-010588 · form4.xml · derivative · entry 2 Matas Barbara Ruth · CIK 0001671249 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,708.63 Underlying: Common Stock · 179.39 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:01 UTC |
Nedorostek Kathleen LDirector
|
GrantPhantom Stock · Derivative | 152.48 | $139.36 | $21,249.61 |
DisclosureSEC source: 0001127602-21-010587 · form4.xml · derivative · entry 2 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,730.73 Underlying: Common Stock · 152.48 shares Expires not disclosed F2 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.exercise_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. F2 · derivative.expiration_date: Each share of Phantom Stock is the economic equivalent of one share of Common Stock. The shares of Phantom Stock become payable in Common Stock, at the election of the reporting person. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:03 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $18.81 | $0.00 |
DisclosureSEC source: 0001127602-21-009389 · form4.xml · derivative · entry 5 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,790 Underlying: Common Stock · 10,000 shares Expires 2026-03-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:03 UTC |
Ibach Shelly RadueDirector · President and CEO
|
SaleCommon Stock | 10,000 | $145.22 | $1,452,200.00 |
DisclosureSEC source: 0001127602-21-009389 · form4.xml · nonDerivative · entry 2 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices between $145.00 and $145.36, inclusive. The reporting person will provide the SEC Staff, Sleep Number or any security holder of Sleep Number, upon request, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 39,083 restricted stock units which the reporting person has deferred. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:03 UTC |
Ibach Shelly RadueDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,000 | $18.81 | $188,100.00 |
DisclosureSEC source: 0001127602-21-009389 · form4.xml · nonDerivative · entry 1 Ibach Shelly Radue · CIK 0001393812 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:01 UTC |
Hellfeld Samuel RSVP Chief Legal & Risk Officer
|
SaleCommon Stock | 3,782 | $146.00 | $552,172.00 |
DisclosureSEC source: 0001127602-21-009388 · form4.xml · nonDerivative · entry 1 Hellfeld Samuel R · CIK 0001750478 · SVP Chief Legal & Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,176 F1 · balance_after: Includes 3,082 shares pursuant to restricted stock unit awards. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 392 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · derivative · entry 7 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783 Underlying: Common Stock · 392 shares Expires 2029-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/29/20, 3/29/21 and 3/29/22. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 511 | $0.00 Strike: $34.35 | $0.00 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · derivative · entry 6 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512 Underlying: Common Stock · 511 shares Expires 2028-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/21/19, 3/21/20 and 3/21/21. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 733 | $0.00 Strike: $23.61 | $0.00 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · derivative · entry 5 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 733 shares Expires 2027-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option grant is fully vested and exercisable. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
SaleCommon Stock | 1,636 | $143.09 | $234,095.24 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · nonDerivative · entry 4 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,168 F1 · balance_after: Includes 1,168 shares from Restricted Stock Unit awards that vest over time. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionCommon Stock | 392 | $47.00 | $18,424.00 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · nonDerivative · entry 3 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionCommon Stock | 511 | $34.35 | $17,552.85 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · nonDerivative · entry 2 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:00 UTC |
Poirier Robert JosephVP, CAO
|
Exercise / conversionCommon Stock | 733 | $23.61 | $17,306.13 |
DisclosureSEC source: 0001127602-21-009092 · form4.xml · nonDerivative · entry 1 Poirier Robert Joseph · CIK 0001788270 · VP, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
SaleCommon Stock | 4,000 | $138.10 | $552,396.40 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · nonDerivative · entry 5 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,996 F1 · balance_after: Includes 1,815 restricted stock units that will vest over time. Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
SaleCommon Stock | 3,370 | $138.42 | $466,475.74 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · nonDerivative · entry 4 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,996 Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,495 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · derivative · entry 8 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,495 shares Expires 2025-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,499 | $0.00 Strike: $27.45 | $0.00 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · derivative · entry 7 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,499 shares Expires 2022-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,376 | $0.00 Strike: $17.34 | $0.00 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · derivative · entry 6 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,376 shares Expires 2021-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionCommon Stock | 1,495 | $30.50 | $45,597.50 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · nonDerivative · entry 3 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionCommon Stock | 2,499 | $27.45 | $68,597.55 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · nonDerivative · entry 2 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:10 UTC |
Nedorostek Kathleen LDirector
|
Exercise / conversionCommon Stock | 3,376 | $17.34 | $58,539.84 |
DisclosureSEC source: 0001127602-21-008305 · form4.xml · nonDerivative · entry 1 Nedorostek Kathleen L · CIK 0001519925 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:04 UTC |
Bloomquist Andrea LeeEVP, Chief Innovation Officer
|
SaleCommon Stock | 2,500 | $128.41 | $321,025.00 |
DisclosureSEC source: 0001127602-21-007269 · form4.xml · nonDerivative · entry 1 Bloomquist Andrea Lee · CIK 0001551521 · EVP, Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,534 Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:03 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,955 | $0.00 Strike: $23.61 | $0.00 |
DisclosureSEC source: 0001127602-21-007266 · form4.xml · derivative · entry 4 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,955 shares Expires 2027-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: This stock option is fully vested and exercisable. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:03 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
SaleCommon Stock | 1,955 | $121.86 | $238,236.30 |
DisclosureSEC source: 0001127602-21-007266 · form4.xml · nonDerivative · entry 2 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,970 Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:03 UTC |
Krusmark Christopher DSVP & Chief H.R. Officer
|
Exercise / conversionCommon Stock | 1,955 | $23.61 | $46,157.55 |
DisclosureSEC source: 0001127602-21-007266 · form4.xml · nonDerivative · entry 1 Krusmark Christopher D · CIK 0001816177 · SVP & Chief H.R. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:02 UTC |
Saklad Joseph HunterEVP, Chief Supply Chain Office
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,835 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001127602-21-007264 · form4.xml · derivative · entry 4 Saklad Joseph Hunter · CIK 0001604680 · EVP, Chief Supply Chain Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,730 Underlying: Common Stock · 1,835 shares Expires 2029-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option becomes exercisable with respect to 1/3 of the shares on each of 3/29/20, 3/29/21 and 3/29/22. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.